An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer.


Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 23 04 2020
accepted: 07 09 2020
pubmed: 8 10 2020
medline: 21 9 2021
entrez: 7 10 2020
Statut: ppublish

Résumé

The aim of this study was to investigate whether bone mineral density (BMD) as measured in planning computed tomographies (CTs) by a new method is a risk factor for pelvic insufficiency fractures (PIF) after radio(chemo)therapy (R(C)T) for cervical cancer. 62 patients with cervical cancer who received definitive or adjuvant radio(chemo)therapy between 2013 and 2017 were reviewed. The PIF were detected on follow-up magntic resonance imaging (MRI). The MRI of the PIF patients was registered to the planning CT and the PIF contoured. On the contralateral side of the fracture, a mirrored structure of the fracture was generated (mPIF). For the whole sacral bone, three lumbar vertebrae, the first and second sacral vertebrae, and the PIF, we analyzed the BMD (mg/cm Out of 62 patients, 6 (9.7%) had a fracture. Two out of the 6 patients had a bilateral fracture with only one of them being symptomatic. PIF patients showed a significantly lower BMD in the sacral and the lumbar vertebrae (p < 0.05). The BMD of the contoured PIF, however, when comparing to the mPIF, did not reach significance (p < 0.49). The difference of the V50Gy of the sacrum in the PIF group compared to the other (OTH) patients, i.e. those without PIF, did not reach significance. The dose does not seem to have a relevant impact on the incidence of PIF in our patients. One of the predisposing factors for developing PIF after radiotherapy seems to be the low BMD. We presented an easy method to assess the BMD in planning CTs.

Identifiants

pubmed: 33025097
doi: 10.1007/s00066-020-01690-0
pii: 10.1007/s00066-020-01690-0
pmc: PMC8154790
doi:

Substances chimiques

Minerals 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

487-493

Références

N Engl J Med. 1999 Apr 15;340(15):1144-53
pubmed: 10202165
Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):475-484
pubmed: 31580930
J Radiat Res. 2013 Nov 1;54(6):1102-9
pubmed: 23685668
Cancer. 2010 Feb 1;116(3):625-30
pubmed: 20052724
Br J Radiol. 2017 May;90(1073):20160885
pubmed: 28291401
Gynecol Oncol. 1999 May;73(2):177-83
pubmed: 10329031
AJNR Am J Neuroradiol. 2014 Aug;35(8):1628-33
pubmed: 24627455
Gynecol Oncol. 2002 Sep;86(3):264-8
pubmed: 12217746
Radiology. 1985 Jul;156(1):15-20
pubmed: 4001403
AJR Am J Roentgenol. 1996 Nov;167(5):1205-10
pubmed: 8911181
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e195-200
pubmed: 22583605
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):973-82
pubmed: 22898381
N Engl J Med. 1999 Apr 15;340(15):1154-61
pubmed: 10202166
Eur J Radiol. 2009 Sep;71(3):398-405
pubmed: 19700255
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1032-1039
pubmed: 28332986
JAMA. 1995 Aug 2;274(5):387-93
pubmed: 7616634
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1183-8
pubmed: 17919836
N Engl J Med. 1999 Apr 15;340(15):1137-43
pubmed: 10202164

Auteurs

Drilon Kurrumeli (D)

Department of Radiation Oncology, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany.
School of Medicine, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany.

Markus Oechsner (M)

Department of Radiation Oncology, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany.

Bianca Weidenbächer (B)

Department of Radiation Oncology, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany.

Christine Brambs (C)

Department of Gynaecology, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany.

Maximilian Löffler (M)

Department of Neuroradiology, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany.

Stephanie Elisabeth Combs (SE)

Department of Radiation Oncology, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany.
Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München (HMGU), Munich, Germany.
German Cancer Consortium (DKTK)-Partner Site Munich, Munich, Germany.

Kai Borm (K)

Department of Radiation Oncology, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany.

Marciana Nona Duma (MN)

School of Medicine, Klinikum rechts der Isar - Technical University of Munich (TUM), Munich, Germany. marciana-nona.duma@med.uni-jena.de.
Department of Radiotherapy and Radiation Oncology, University Hospital Jena, Bachstr. 18, 07743, Jena, Germany. marciana-nona.duma@med.uni-jena.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH